“…Such non-genetic heterogeneity has been indicated in immune cell functionality (Feinerman et al, 2010; Shalek et al, 2013) and has also been suggested as a driving force of stem cell development and cell fate decisions, such as lineage choice in hematopoietic stem cells (Chambers et al, 2007; Chang et al, 2008; Dietrich & Hiiragi, 2007; Kalmar et al, 2009; Kobayashi et al, 2009; Singh et al, 2007; Stockholm et al, 2007). Cellular heterogeneity is also an underlying source of the development of phenotypically different subpopulations due to individual cell responses to changes in microenvironment within genetically identical populations (Neildez-Nguyen et al, 2008). Such functional subgroups can also have substantial pharmacological consequences, notably with regards to cancer treatment, where partial drug resistance in tumor cell populations poses a significant problem (Cohen et al, 2008; Gascoigne & Taylor, 2008; Niepel, Spencer & Sorger, 2009; Orth et al, 2008; Sharma et al, 2010; Shi, Orth & Mitchison, 2008).…”